Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ricki Louise Fairley Insider Profile
4 Followers
Ricki Louise Fairley, Director at Xeris Pharmaceuticals, holds 135.00K shares in Xeris Pharmaceuticals (Ticker: XERS).
Ricki Louise Fairley has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Ricki Louise Fairley's holdings
Insider Roles
Director
Roles that Ricki Louise Fairley holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Ricki Louise Fairley
Ricki Louise Fairley's Trading History
List of latest transactions for each holding click on a transaction to see Ricki Louise Fairley's performance on stock
You May Also Like
Ricki Louise Fairley insider profile FAQ
What is the percentage of profitable transactions made by Ricki Louise Fairley?
The percentage of profitable transactions made by Ricki Louise Fairley is ―.
What is the average return per transaction made by Ricki Louise Fairley?
The average return per transaction made by Ricki Louise Fairley is ―.
What stocks does Ricki Louise Fairley hold?
Ricki Louise Fairley holds: XERS stocks.
What was Ricki Louise Fairley’s latest transaction?
Ricki Louise Fairley latest transaction was an Uninformative Buy of ―.
What was Ricki Louise Fairley's most profitable transaction?
Ricki Louise Fairley’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ricki Louise Fairley's role in Xeris Pharmaceuticals?
Ricki Louise Fairley's role in Xeris Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.